sales@scalarmarketresearch.com  |   +1-800-213-5170  (U.S./ Canada Toll-free)  |  REGISTER |  SIGN IN

Home >> Reports >> critical care diagnostics market

report

Critical Care Diagnostics Market, by Types (Flow Cytometry, Routine & Special Chemistry, Hematology, Microbial and Infectious Diseases, Immunoproteins, Coagulation Test, Others), End-users (Hospitals, Research Labs, Ambulatory Surgical Centers, Others) - Global Revenue, Trends, Growth, Share, Size, and Forecast to 2022

HC230 January 2017 100+ FREE 10% CUSTOMIZATION

The objective of this report is to describe the market trends and revenue forecasts for the critical care diagnostics market for the next five years. The report focuses on defining and describing the key influencing factors for the growth of the market. It also offers an in-depth analysis of the market size (revenue), market share, major market segments, different geographic regions, key market players, and premium industry trends.

The report tracks the major market events including product launches, technological developments, mergers & acquisitions, and the innovative business strategies opted by key market players. Along with strategically analyzing the key micro markets, the report also focuses on industry-specific drivers, restraints, opportunities and challenges in the critical care diagnostics market. The scope of this report covers the critical care diagnostics market by its major segments, which include the type, end-users, and the major geographic regions.

KEY BENEFITS OF THE REPORT

  • Extensive evaluation of all the market dynamics that will impact this market during the forecast period
  • Granular understanding of the historical market trend and the resultant market forecast
  • Deeper understanding of the behavior of the key players and innovators influencing this market

KEY PREMIUM INDUSTRY INSIGHTS

  • The growing awareness of this test among the medical practitioner and patients, rise in the aging population, increasing incidences of chronic disorders such as heart diseases, diabetes & cancer are some of the factors expected to drive the critical care diagnostics market growth.
  • However, less technological acceptance in the emerging market and the rising cost of molecular diagnostics is likely to hamper the market growth.

RESEARCH METHODOLOGY

The research methodology for Scalar Market Research’s critical care diagnostics market report utilizes a combination of top-down and bottom-up research formats. Our primary focus on continuous market tracking, rigorous fact-checking, data-triangulation, and multiple layers of quality control ensures high-quality data that can be leveraged for actionable research insights.

Critical Care Diagnostics Market,

To know about the assumptions considered for the study, Download PDF Sample.

MARKET SEGMENTATION

This report analyzes the critical care diagnostics market by the following segments:

  • Critical Care Diagnostics Market, by Types
    • Flow Cytometry
    • Routine And Special Chemistry
    • Hematology
    • Microbial and Infectious Diseases
    • Immunoproteins
    • Coagulation Test
    • Others
  • Critical Care Diagnostics Market, by End-users
    • Hospitals
    • Research Labs
    • Ambulatory Surgical Centers
    • Others

KEY MARKET PLAYERS

Key players in the critical care diagnostics market include:

  • Abbott.
  • F. Hoffmann-La Roche Ltd
  • Beckman Coulter, Inc.
  • Becton Dickinson and Company
  •  Nanōmix, Inc. 
  • Bio-Rad Laboratories, Inc
  • Sysmex Corporation
  • Siemens Ltd
  • Nova Biomedical
  • Biosensors International Group, Ltd.

GEOGRAPHIC COVERAGE AND ANALYSIS

This granular market research report covers the following geographic regions in great detail:

  • NORTH AMERICA
    • U.S.
    • Rest of North America
  • EUROPE
    • France
    • Germany
    • U.K.
    • Rest of Europe
  • ASIA-PACIFIC
    • China
    • India
    • Japan
    • Rest of Asia-Pacific
  • REST OF THE WORLD
    • Latin America
    • Middle East & Africa

Critical Care Diagnostics Market

TRENDING RELATED REPORT


  1. MARKET OVERVIEW
    1. Market Definitions
    2. Research Methodology
    3. Market Segmentation
  2. EXECUTIVE SUMMARY
  3. MARKET DYNAMICS
    1. Drivers
    2. Restraints
    3. Opportunities
    4. Premium Industry Trends
  4. INDUSTRY ANALYSIS
    1. Value Chain Analysis
    2. Regulatory Analysis
    3. Ecosystem Analysis
  5. CRITICAL CARE DIAGNOSTICS MARKET, BY TYPES
    1. Segment Share
    2. Types
      1. Flow Cytometry
      2. Routine And Special Chemistry
      3. Hematology
      4. Microbial and Infectious Diseases
      5. Immunoproteins
      6. Coagulation Test
      7. Others
  6. CRITICAL CARE DIAGNOSTICS MARKET, BY END-USERS
    1. Segment Share
    2. End-users
      1. Hospitals
      2. Research Labs
      3. Ambulatory Surgical Centers
      4. Others
  7. CRITICAL CARE DIAGNOSTICS MARKET, BY GEOGRAPHY
    1. North America
      1. By Regions
        1. U.S.
        2. Rest of North America
      2. By Types
      3. By End-users
    2. Europe
      1. By Regions
        1. France
        2. Germany
        3. U.K.
        4. Rest of Europe
      2. By Types
      3. By End-users
    3. Asia-Pacific
      1. By Regions
        1. China
        2. India
        3. Japan
        4. Rest of Asia-Pacific
      2. By Types
      3. By End-users
    4. Rest of the World
      1. By Regions
        1. Latin America
        2. Middle East and Africa
      2. By Types
      3. By End-users
  8. COMPETITIVE LANDSCAPE
    1. Market Positioning of Key Players, 2015
    2. Key Innovators
  9. KEY MARKET PLAYERS
    1. Abbott.
      1. Overview
      2. Key Strategies
      3. Recent Developments
    2. F. Hoffmann-La Roche Ltd
      1. Overview
      2. Key Strategies
      3. Recent Developments
    3. Beckman Coulter, Inc.
      1. Overview
      2. Key Strategies
      3. Recent Developments
    4. Becton Dickinson and Company
      1. Overview
      2. Key Strategies
      3. Recent Developments
    5.  Nanōmix, Inc. 
      1. Overview
      2. Key Strategies
      3. Recent Developments
    6. Bio-Rad Laboratories, Inc
      1. Overview
      2. Key Strategies
      3. Recent Developments
    7. Sysmex Corporation
      1. Overview
      2. Key Strategies
      3. Recent Developments
    8. Siemens Ltd
      1. Overview
      2. Key Strategies
      3. Recent Developments
    9. Nova Biomedical
      1. Overview
      2. Key Strategies
      3. Recent Developments
    10. Biosensors International Group, Ltd.
      1. Overview
      2. Key Strategies
      3. Recent Developments
  10. SCALAR 360 DEGREE MARKET PERSPECTIVE
  11. APPENDIX
Please submit your enquiry below so our representative can get in touch with you
*
*
*
*
*
*
*

USA - CANADA TOLL FREE
+1-800-213-5170
EMAIL
sales@scalarmarketresearch.com

Benefits of Buying From Scalar

  • Unparalleled Expertise

    Our industry experts hold inimitable know-how across wide range of industry verticals

  • Assured Quality

    We deliver high-quality, real-time and data-driven industry insights to our clients

  • 24x7 Analyst Support

    We offer pre-purchase and post-purchase support from our industry experts

  • Privacy & Security

    All your personal information and confidential details are safe and secure with us